Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-062720
Filing Date
2011-06-29
Accepted
2011-06-29 13:50:23
Documents
8
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c19282e10vk.htm 10-K 745091
2 EXHIBIT 21 c19282exv21.htm EX-21 1772
3 EXHIBIT 23.1 c19282exv23w1.htm EX-23.1 1596
4 EXHIBIT 23.2 c19282exv23w2.htm EX-23.2 1620
5 EXHIBIT 31.1 c19282exv31w1.htm EX-31.1 5912
6 EXHIBIT 31.2 c19282exv31w2.htm EX-31.2 5920
7 EXHIBIT 32.1 c19282exv32w1.htm EX-32.1 3645
8 GRAPHIC c19282c1928201.gif GRAPHIC 7702
  Complete submission text file 0000950123-11-062720.txt   777496
Mailing Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111
Business Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111 (303) 867-3415
OMNI BIO PHARMACEUTICAL, INC. (Filer) CIK: 0001389870 (see all company filings)

EIN.: 208097969 | State of Incorp.: CO | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-52530 | Film No.: 11938248
SIC: 2836 Biological Products, (No Diagnostic Substances)